BSX (Boston Scientific Corp) Return on Gross Profit

Corporate emblem and logo of Boston Scientific Corp (BSX)

Boston Scientific attracts leading engineers through a culture of quality and stable development. The integration of precision implants and physician training has created a robust ecosystem, as reflected in the current gross margin, where 65.60 represents the latest metric reading. The implementation of the Farapulse system drives current growth, while potential in urology forms future expansion drivers.

bostonscientific.com (BSX) Gross Profitability: for the period 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for Boston Scientific Corp (BSX)

- business market valuation indicators:
Basic company analysis:BSX (Boston Scientific Inc)
Manufactured products of Boston Scientific Corporation

The dynamics of this metric directly reflect the operational efficiency of cost management. Gross margin measures the portion of revenue that remains with the company after paying all direct production expenses. For Boston Scientific (BSX), packaging optimization and the implementation of ESG standards at factories allow for a reduction in the cost of goods sold. By analyzing the gross profit margin, an investor can assess the resilience of the business model to market fluctuations.

Key competitors

Return on Gross Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Gross Margin|OmniPod (PODD) - Return on Sales by Gross Profit|Gross Margin ZBH|Gross Margin coopercos.com (COO)|Gross Margin ALGN (aligntech.com)|Gross Margin Globus Medical Inc GMED|TMDX - Gross Profitability|ATEC: Gross Profitability|AORT (Artivion, Inc.) - Return on Gross Profit|Enovis Corporation - Gross Profit Rate|IART (Integra LifeSciences Inc.) - Gross Margin|Gross Profit Margin Establishment Labs Corp ESTA|Gross Profitability Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO